BMRN(BioMarin Pharmaceutical Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $1.85B | $2.10B | $2.42B | $2.85B | $3.22B |
| 毛利润 | $1.38B | $1.59B | $1.89B | $2.27B | $2.50B |
| 营业利润 | −$82.34M | $160.97M | $185.77M | $484.21M | $409.48M |
| 净利润 | −$64.08M | $141.56M | $167.65M | $426.86M | $348.90M |
| 经营现金流 | $304.54M | $175.90M | $159.26M | $572.84M | $827.99M |
| 自由现金流 | $208.96M | $54.94M | $62.57M | $487.42M | $724.96M |
| 摊薄每股收益 | $-0.35 | $0.75 | $0.87 | $2.21 | $1.80 |